Sigachi Industries Limited (SIGACHI.BO)
INR 37.97
(2.48%)
INR 37.97
(2.48%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 883.39 Million INR | 18.48% |
| 2022 | 653.96 Million INR | 16.76% |
| 2021 | 556.74 Million INR | 33.3% |
| 2020 | 420.44 Million INR | 43.19% |
| 2019 | 296.45 Million INR | -0.8% |
| 2018 | 298.51 Million INR | 111.68% |
| 2017 | 138.24 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 210.25 Million INR | -3.71% |
| 2023 Q3 | 242.97 Million INR | 7.87% |
| 2023 Q2 | 225.24 Million INR | 25.54% |
| 2023 Q4 | 163.31 Million INR | -32.78% |
| 2023 Q1 | 179.41 Million INR | 43.24% |
| 2023 FY | - INR | 18.48% |
| 2022 Q4 | 125.25 Million INR | -18.14% |
| 2022 Q3 | 153.01 Million INR | -17.22% |
| 2022 Q2 | 184.84 Million INR | 3.35% |
| 2022 Q1 | 178.85 Million INR | 12.65% |
| 2022 FY | - INR | 16.76% |
| 2021 Q2 | 137.21 Million INR | 10.81% |
| 2021 FY | - INR | 33.3% |
| 2021 Q4 | 158.77 Million INR | 20.41% |
| 2021 Q3 | 131.86 Million INR | -3.9% |
| 2021 Q1 | 123.83 Million INR | 6.35% |
| 2020 FY | - INR | 43.19% |
| 2020 Q3 | 93.01 Million INR | -3.7% |
| 2020 Q2 | 96.58 Million INR | -2.03% |
| 2020 Q1 | 98.59 Million INR | 0.0% |
| 2020 Q4 | 116.43 Million INR | 25.18% |
| 2019 FY | - INR | -0.8% |
| 2018 FY | - INR | 111.68% |
| 2017 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 138.36 Billion INR | 99.362% |
| NATCO Pharma Limited | 18.79 Billion INR | 95.3% |
| Suven Pharmaceuticals Limited | 4.67 Billion INR | 81.113% |
| Syncom Formulations (India) Limited | 430.27 Million INR | -105.31% |
| Achyut Healthcare Limited | 524 Thousand INR | -168487.405% |
| Ajanta Pharma Limited | 12.56 Billion INR | 92.97% |
| Alkem Laboratories Limited | 24.19 Billion INR | 96.349% |
| Alpa Laboratories Limited | 86.12 Million INR | -925.692% |
| Alembic Pharmaceuticals Limited | 9.61 Billion INR | 90.814% |
| AstraZeneca Pharma India Limited | 2.35 Billion INR | 62.517% |
| Aurobindo Pharma Limited | 61.78 Billion INR | 98.57% |
| Bajaj HealthCare Limited | 444.51 Million INR | -98.733% |
| Bliss GVS Pharma Limited | 1.47 Billion INR | 40.272% |
| Brooks Laboratories Limited | 41.72 Million INR | -2017.039% |
| Divi's Laboratories Limited | 25.43 Billion INR | 96.526% |
| Dr. Reddy's Laboratories Limited | 88.27 Billion INR | 98.999% |
| Eris Lifesciences Limited | 6.98 Billion INR | 87.356% |
| FDC Limited | 4.4 Billion INR | 79.93% |
| Glenmark Pharmaceuticals Limited | 11.34 Billion INR | 92.212% |
| Glenmark Life Sciences Limited | 6.86 Billion INR | 87.128% |
| Granules India Limited | 8.6 Billion INR | 89.732% |
| Gufic Biosciences Limited | 1.48 Billion INR | 40.331% |
| Hester Biosciences Limited | 539.47 Million INR | -63.753% |
| Indoco Remedies Limited | 2.64 Billion INR | 66.627% |
| Ind-Swift Laboratories Limited | 6.86 Billion INR | 87.126% |
| Ipca Laboratories Limited | 13.29 Billion INR | 93.358% |
| Jagsonpal Pharmaceuticals Limited | 323.46 Million INR | -173.109% |
| Krebs Biochemicals & Industries Limited | -82.72 Million INR | 1167.847% |
| Lasa Supergenerics Limited | -65.08 Million INR | 1457.403% |
| Laurus Labs Limited | 8 Billion INR | 88.966% |
| Lupin Limited | 36.96 Billion INR | 97.61% |
| Mankind Pharma Limited | 28.09 Billion INR | 96.856% |
| Medicamen Biotech Limited | 245.66 Million INR | -259.602% |
| Medico Remedies Limited | 150.37 Million INR | -487.452% |
| Megasoft Limited | 284.73 Million INR | -210.257% |
| Piramal Pharma Limited | 13.05 Billion INR | 93.233% |
| RPG Life Sciences Limited | 1.28 Billion INR | 31.065% |
| Sun Pharma Advanced Research Company Limited | -3.73 Billion INR | 123.676% |
| Unichem Laboratories Limited | 742.35 Million INR | -18.999% |
| Wanbury Limited | 985.49 Million INR | 10.36% |
| Windlas Biotech Limited | 781.72 Million INR | -13.007% |
| ZIM Laboratories Limited | 462.09 Million INR | -91.172% |
| Zydus Lifesciences Limited | 56.22 Billion INR | 98.429% |
| Procter & Gamble Health Limited | 3.01 Billion INR | 70.694% |
| Amrutanjan Health Care Limited | 682.53 Million INR | -29.428% |
| Bal Pharma Limited | 345.59 Million INR | -155.619% |
| Strides Pharma Science Limited | 3.76 Billion INR | 76.535% |
| Venus Remedies Limited | 711.8 Million INR | -24.107% |
| Aarti Pharmalabs Limited | 3.9 Billion INR | 77.403% |
| Nectar Lifesciences Limited | 1.56 Billion INR | 43.509% |
| Shilpa Medicare Limited | 2.58 Billion INR | 65.865% |
| Aarti Drugs Limited | 3.24 Billion INR | 72.807% |
| IOL Chemicals and Pharmaceuticals Limited | 2.6 Billion INR | 66.109% |
| Suven Life Sciences Limited | -992.78 Million INR | 188.982% |
| Ind-Swift Limited | 1.06 Billion INR | 17.057% |
| Valiant Laboratories Limited | 12.73 Million INR | -6834.595% |
| J. B. Chemicals & Pharmaceuticals Limited | 9.33 Billion INR | 90.537% |
| Solara Active Pharma Sciences Limited | -2.82 Billion INR | 131.305% |
| Themis Medicare Limited | 562.6 Million INR | -57.019% |
| Hikal Limited | 2.69 Billion INR | 67.187% |
| Torrent Pharmaceuticals Limited | 35 Billion INR | 97.477% |
| Sequent Scientific Limited | 549.8 Million INR | -60.676% |
| Novartis India Limited | 1.26 Billion INR | 30.403% |
| Wockhardt Limited | 1.08 Billion INR | 18.204% |
| Jubilant Pharmova Limited | 8 Billion INR | 88.966% |
| Biofil Chemicals and Pharmaceuticals Limited | 13.06 Million INR | -6663.114% |
| Neuland Laboratories Limited | 4.74 Billion INR | 81.395% |
| Morepen Laboratories Limited | 1.72 Billion INR | 48.817% |
| Kilitch Drugs (India) Limited | 287.42 Million INR | -207.349% |
| Mangalam Drugs & Organics Limited | 174.94 Million INR | -404.955% |